Related references
Note: Only part of the references are listed.Association of Renal Stress/Damage and Filtration Biomarkers with Subsequent AKI during Hospitalization among Patients Presenting to the Emergency Department
Martin Kimmel et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Urinary kidney injury molecule-1 and monocyte chemotactic protein-1 are noninvasive biomarkers of cisplatin-induced nephrotoxicity in lung cancer patients
Haruka Shinke et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2015)
Tissue Inhibitor Metalloproteinase-2 (TIMP-2)IGF-Binding Protein-7 (IGFBP7) Levels Are Associated with Adverse Long-Term Outcomes in Patients with AKI
Jay L. Koyner et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Urinary Biomarkers TIMP-2 and IGFBP7 Early Predict Acute Kidney Injury after Major Surgery
Ivan Gocze et al.
PLoS One (2015)
Validation of Cell-Cycle Arrest Biomarkers for Acute Kidney Injury Using Clinical Adjudication
Azra Bihorac et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers
Eric A. J. Hoste et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Urinary TIMP-2 and IGFBP7 as Early Biomarkers of Acute Kidney Injury and Renal Recovery following Cardiac Surgery
Melanie Meersch et al.
PLOS ONE (2014)
Urinary neutrophil gelatinase-associated lipocalin levels predict cisplatin-induced acute kidney injury better than albuminuria or urinary cystatin C levels
Hugo You-Hsien Lin et al.
KAOHSIUNG JOURNAL OF MEDICAL SCIENCES (2013)
Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury
Kianoush Kashani et al.
CRITICAL CARE (2013)
Predicting Cisplatin-Induced Acute Kidney Injury by Urinary Neutrophil Gelatinase-Associated Lipocalin Excretion: A Pilot Prospective Case-Control Study
Flavio Gaspari et al.
NEPHRON CLINICAL PRACTICE (2010)
The cell cycle and acute kidney injury
Peter M. Price et al.
KIDNEY INTERNATIONAL (2009)
Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care
Vincent Launay-Vacher et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Two faces of p53: aging and tumor suppression
Francis Rodier et al.
NUCLEIC ACIDS RESEARCH (2007)
Cisplatin nephrotoxicity: A review
Xin Yao et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2007)
Cisplatin-induced acute renal failure is associated with an increase in the cytokines interleukin (IL)-1β, IL-18, IL-6, and neutrophil infiltration in the kidney
Sarah Faubel et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Shp-1 mediates the antiproliferative activity of tissue inhibitor of metalloproteinase-2 in human microvascular endothelial cells
DW Seo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Share Paper
